TY 10957

stable PGI2 analog; structure given in first source

Also Known As:

3-(3-oxa-4-carboxybutyl)-7-exo-(3-hydroxy-4-methyl-4-phenoxy-1-pentenyl)-8-endo-hydroxybicyclo(4.3.0)non-2-ene; TY-10957; Acetic acid, (2-(2,3,3a,6,7,7a-hexahydro-2-hydroxy-1-(3-hydroxy-4-methyl-4-phenoxy-1-pentenyl)-1H-inden-5-yl)ethoxy)-, (1alpha(1E,3R*),2beta,3aalpha,7aalpha)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins I: 108
        Epoprostenol: 4670
        TY 10957: 1
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins I: 108
        Epoprostenol: 4670
        TY 10957: 1

Related Diseases

1.	Duodenal Ulcer (Curling's Ulcer) 01/01/1990 - "Orally administered TY-10957 dose dependently prevented gastric lesions induced by ethanol/HC1 (60% ethanol in 150 mM HCl) and duodenal ulcers induced by mepirizole (200 mg/kg); a significant effect was obtained at 3 micrograms/kg or greater in the former and at 300 micrograms/kg in the latter. "

Related Drugs and Biologics

1.	Epirizole
2.	Ethanol (Ethyl Alcohol)